These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33693736)

  • 1. Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry.
    Cittadini A; Salzano A; Iacoviello M; Triggiani V; Rengo G; Cacciatore F; Maiello C; Limongelli G; Masarone D; Perticone F; Cimellaro A; Perrone Filardi P; Paolillo S; Mancini A; Volterrani M; Vriz O; Castello R; Passantino A; Campo M; Modesti PA; De Giorgi A; Monte IP; Puzzo A; Ballotta A; D'Assante R; Arcopinto M; Gargiulo P; Sciacqua A; Bruzzese D; Colao A; Napoli R; Suzuki T; Eagle KA; Ventura HO; Marra AM; Bossone E;
    Eur J Prev Cardiol; 2021 Dec; 28(15):1691-1700. PubMed ID: 33693736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry.
    Bossone E; Arcopinto M; Iacoviello M; Triggiani V; Cacciatore F; Maiello C; Limongelli G; Masarone D; Perticone F; Sciacqua A; Perrone-Filardi P; Mancini A; Volterrani M; Vriz O; Castello R; Passantino A; Campo M; Modesti PA; De Giorgi A; Monte I; Puzzo A; Ballotta A; Caliendo L; D'Assante R; Marra AM; Salzano A; Suzuki T; Cittadini A;
    Intern Emerg Med; 2018 Aug; 13(5):661-671. PubMed ID: 29619769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on the Article "Multiple Hormonal and Metabolic Deficiency Syndrome Predicts Outcome in Heart Failure: The T.O.S.CA. Registry", Antonio Cittadini
    Triggiani V; Lisco G
    Endocr Metab Immune Disord Drug Targets; 2022; 22(6):545-548. PubMed ID: 34911431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry.
    Marra AM; D'Assante R; Salzano A; Iacoviello M; Triggiani V; Rengo G; Limongelli G; Masarone D; Perticone M; Cimellaro A; Perrone Filardi P; Paolillo S; Gargiulo P; Mancini A; Volterrani M; Vriz O; Castello R; Passantino A; Campo M; Modesti PA; De Giorgi A; Arcopinto M; D'Agostino A; Raparelli V; Isidori AM; Valente V; Giardino F; Crisci G; Sciacqua A; Savoia M; Suzuki T; Bossone E; Cittadini A;
    ESC Heart Fail; 2023 Feb; 10(1):159-166. PubMed ID: 36134448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-1 (IGF-1) as predictor of cardiovascular mortality in heart failure patients: data from the T.O.S.CA. registry.
    De Giorgi A; Marra AM; Iacoviello M; Triggiani V; Rengo G; Cacciatore F; Maiello C; Limongelli G; Masarone D; Perticone F; Filardi PP; Paolillo S; Mancini A; Volterrani M; Vriz O; Castello R; Passantino A; Campo M; Modesti PA; Salzano A; D'Assante R; Arcopinto M; Raparelli V; Fabbian F; Sciacqua A; Colao A; Suzuki T; Bossone E; Cittadini A;
    Intern Emerg Med; 2022 Sep; 17(6):1651-1660. PubMed ID: 35445917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry.
    Salzano A; D'Assante R; Iacoviello M; Triggiani V; Rengo G; Cacciatore F; Maiello C; Limongelli G; Masarone D; Sciacqua A; Filardi PP; Mancini A; Volterrani M; Vriz O; Castello R; Passantino A; Campo M; Modesti PA; De Giorgi A; Arcopinto M; Gargiulo P; Perticone M; Colao A; Milano S; Garavaglia A; Napoli R; Suzuki T; Bossone E; Marra AM; Cittadini A;
    Cardiovasc Diabetol; 2022 Jun; 21(1):108. PubMed ID: 35710369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-1 predicts survival in chronic heart failure. Insights from the T.O.S.CA. (Trattamento Ormonale Nello Scompenso CArdiaco) registry.
    Arcopinto M; Isgaard J; Marra AM; Formisano P; Bossone E; Vriz O; Vigorito C; Saccà L; Douglas PS; Cittadini A
    Int J Cardiol; 2014 Oct; 176(3):1006-8. PubMed ID: 25037691
    [No Abstract]   [Full Text] [Related]  

  • 8. Anabolic Hormones Deficiencies in Heart Failure With Preserved Ejection Fraction: Prevalence and Impact on Antioxidants Levels and Myocardial Dysfunction.
    Bruno C; Silvestrini A; Calarco R; Favuzzi AMR; Vergani E; Nicolazzi MA; d'Abate C; Meucci E; Mordente A; Landolfi R; Mancini A
    Front Endocrinol (Lausanne); 2020; 11():281. PubMed ID: 32477267
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
    Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
    Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
    Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
    J Cardiol; 2019 Jun; 73(6):459-465. PubMed ID: 30718015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.
    Shah AM; Claggett B; Sweitzer NK; Shah SJ; Anand IS; O'Meara E; Desai AS; Heitner JF; Li G; Fang J; Rouleau J; Zile MR; Markov V; Ryabov V; Reis G; Assmann SF; McKinlay SM; Pitt B; Pfeffer MA; Solomon SD
    Circ Heart Fail; 2014 Sep; 7(5):740-51. PubMed ID: 25122186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction.
    Houard L; Amzulescu MS; Colin G; Langet H; Militaru S; Rousseau MF; Ahn SA; Vanoverschelde JJ; Pouleur AC; Gerber BL
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011680. PubMed ID: 33438438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of moderate mitral regurgitation on hospitalized heart failure patients with preserved ejection fraction: A report from the JASPER registry.
    Oikawa M; Yoshihisa A; Sato Y; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
    Heart Vessels; 2020 Aug; 35(8):1087-1094. PubMed ID: 32193620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right Ventricular Ejection Fraction for the Prediction of Major Adverse Cardiovascular and Heart Failure-Related Events: A Cardiac MRI Based Study of 7131 Patients With Known or Suspected Cardiovascular Disease.
    Purmah Y; Lei LY; Dykstra S; Mikami Y; Cornhill A; Satriano A; Flewitt J; Rivest S; Sandonato R; Seib M; Lydell CP; Howarth AG; Heydari B; Merchant N; Bristow M; Fine N; Gaztanaga J; White JA
    Circ Cardiovasc Imaging; 2021 Mar; 14(3):e011337. PubMed ID: 33722059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone receptor antagonists decrease mortality and cardiovascular hospitalizations in chronic heart failure with reduced left ventricular ejection fraction, but not in chronic heart failure with preserved left ventricular ejection fraction: a meta-analysis of randomized controlled trials.
    DE Vecchis R; Ariano C
    Minerva Cardioangiol; 2017 Aug; 65(4):427-442. PubMed ID: 27958695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure.
    Juillière Y; Suty-Selton C; Riant E; Darracq JP; Dellinger A; Labarre JP; Druelle J; Mulak G; Danchin N; Jourdain P;
    Arch Cardiovasc Dis; 2014 Jan; 107(1):21-32. PubMed ID: 24388162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study.
    González-Costello J; Comín-Colet J; Lupón J; Enjuanes C; de Antonio M; Fuentes L; Moliner-Borja P; Farré N; Zamora E; Manito N; Pujol R; Bayés-Genis A
    BMC Cardiovasc Disord; 2018 Nov; 18(1):206. PubMed ID: 30382817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome.
    Oliva F; Mortara A; Cacciatore G; Chinaglia A; Di Lenarda A; Gorini M; Metra M; Senni M; Maggioni AP; Tavazzi L;
    Eur J Heart Fail; 2012 Nov; 14(11):1208-17. PubMed ID: 22833614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
    Ehteshami-Afshar S; Mooney L; Dewan P; Desai AS; Lang NN; Lefkowitz MP; Petrie MC; Rizkala AR; Rouleau JL; Solomon SD; Swedberg K; Shi VC; Zile MR; Packer M; McMurray JJV; Jhund PS; Hawkins NM
    J Am Heart Assoc; 2021 Feb; 10(4):e019238. PubMed ID: 33522249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.